Moreover, the evidence that both APP and BRI2 tune excitatory synaptic transmission, and that these functions are altered by pathogenic mutations in both APP and BRI2 (37, 41, 46, 54, 55, 56), suggests that early alterations in glutamatergic transmission may underlie initial pathogenic mechanisms in dementia. The gene discussed is APP; the disease is dementia.